Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

What is the Purpose of this Study?

The purpose of this study is to compare different approaches of computerized cognitive training methods in breast cancer survivors with cancer-related cognitive impairment. Specifically, researchers aim to determine whether these patients can make improvements in concentrating, learning new things, remembering, and making decisions that affect daily life by receiving computerized cognitive training. Participants will be randomly assigned to 1 of 2 computerized cognitive training groups for 10 weeks; they will also complete assessments before and up to at least 6 months after training. The computerized cognitive training will be delivered remotely online; trained staff will help participants learn how to use the program. Patients will be asked to complete questionnaires and a cognitive assessment. The study will help determine which approach of computerized cognitive training methods will work better to improve the ability to concentrate, remember, learn new things, and make decisions that affect daily life.


Eligibility

  • * The participant must provide study-specific informed consent prior to any study specific procedures and authorization permitting release of personal health information.
  • * The participant must have a first time diagnosis of non-metastatic breast cancer which is Stage I-III.
  • * The participant must have a score of less than 12 on the PROMIS Adult v2.0 - Cognitive Function 4a.
  • * Participants must be at least 6 months and no more than 5 years (after completion of initial surgery +/- adjuvant chemotherapy/radiation therapy) and targeted therapies (e.g., PARP inhibitors, CDK4/6, or immunotherapy). Participants may still be taking endocrine therapy and/or trastuzumab.
Show more

Where can I participate?

CS Cancer at Cedars-Sinai Medical Center : Ana Martin

More about this Clinical Trial

What is the full name of this clinical trial?

NRG-CC011: Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial

Study Details
Disease Type/Condition

Breast

Principal Investigator

Asher, Arash

Co-Investigators

Philip Chang

Age Group

Adult

Phase

III

IRB Number

STUDY00003746

ClinicalTrials.gov ID

NCT05896189

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Name

Ana Martin

Email
ana.martin@cshs.org
Study Detail
Disease Type/Condition

Breast

Principal Investigator

Asher, Arash

Age Group

Adult

Phase

III

IRB Number

NRG-CC011

ClinicalTrials.gov ID

NCT05896189

Key Eligibility
ClinicalTrials.gov

Contact
Name

Ana Martin

Email
ana.martin@cshs.org